Detalhe da pesquisa
1.
Analysis of seizure-cluster circadian periodicity from a long-term, open-label safety study of diazepam nasal spray.
Epilepsia
; 65(4): 920-928, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38391291
2.
Barriers to Alzheimer Disease Clinical Trial Participation in a Minority Population.
Cogn Behav Neurol
; 37(1): 40-47, 2024 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37878413
3.
A comparison of statistical versus clinical classifiers of seizure clustering in women with catamenial and noncatamenial epilepsy.
Epilepsia
; 64(6): 1507-1515, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36931823
4.
Concomitant cannabidiol does not impact safety and effectiveness of diazepam nasal spray for seizure clusters: Post hoc analysis of a phase 3 safety study.
Epilepsy Behav
; 144: 109248, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210793
5.
Written seizure action plans for adult patients with epilepsy: Distilling insights from emergency action plans for other chronic conditions.
Epilepsy Behav
; 140: 109002, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36822041
6.
Muybridge, Dercum, and the Early Use of Photography in the Study of Psychogenic Non-Epileptic Seizures.
Eur Neurol
; 86(3): 217-221, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36696887
7.
Significant improvements in SEIzure interVAL (time between seizure clusters) across time in patients treated with diazepam nasal spray as intermittent rescue therapy for seizure clusters.
Epilepsia
; 63(10): 2684-2693, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35975599
8.
Use of second doses of Valtoco® (diazepam nasal spray) across 24 hours after the initial dose for out-of-hospital seizure clusters: Results from a phase 3, open-label, repeat-dose safety study.
Epilepsia
; 63(4): 836-843, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35112342
9.
Future opportunities for research in rescue treatments.
Epilepsia
; 63 Suppl 1: S55-S68, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35822912
10.
Lack of clinically relevant differences in safety and pharmacokinetics after second-dose administration of intranasal diazepam within 4 h for acute treatment of seizure clusters: A population analysis.
Epilepsia
; 63(7): 1714-1723, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35377464
11.
Quality-of-life results in adults with epilepsy using diazepam nasal spray for seizure clusters from a long-term, open-label safety study.
Epilepsy Behav
; 134: 108811, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35816831
12.
Native Hawaiian and Other Pacific Islanders' Leading Risk Factors for Ischemic Stroke: A Comparative Ethnographic Study.
J Stroke Cerebrovasc Dis
; 31(6): 106433, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35339856
13.
Overcoming the challenges of developing an intranasal diazepam rescue therapy for the treatment of seizure clusters.
Epilepsia
; 62(4): 846-856, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33617690
14.
Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long-term, open-label safety study.
Epilepsia
; 62(6): 1442-1450, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33942315
15.
Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy.
Epilepsia
; 62(10): 2485-2495, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34418086
16.
Early impact of the COVID-19 pandemic on outpatient migraine care in Hawaii: Results of a quality improvement survey.
Headache
; 61(1): 149-156, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33316097
17.
Lack of observed impact of history or concomitant treatment of seasonal allergies or rhinitis on repeated doses of diazepam nasal spray administered per seizure episode in a day, safety, and tolerability: Interim results from a phase 3, open-label, 12-month repeat-dose safety study.
Epilepsy Behav
; 118: 107898, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33752044
18.
Examining the patient and caregiver experience with diazepam nasal spray for seizure clusters: Results from an exit survey of a phase 3, open-label, repeat-dose safety study.
Epilepsy Behav
; 121(Pt A): 108013, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34022621
19.
Lack of observed tolerance to diazepam nasal spray (Valtoco®) after long-term rescue therapy in patients with epilepsy: Interim results from a phase 3, open-label, repeat-dose safety study.
Epilepsy Behav
; 120: 107983, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33957437
20.
Recommendations for development of acute seizure action plans (ASAPs) from an expert panel.
Epilepsy Behav
; 123: 108264, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34482230